Blueprint Medicines Pre-Tax Income 2014-2024 | BPMC
- Blueprint Medicines annual pre-tax income for 2023 was $-0.506B, a 8.38% decline from 2022.
- Blueprint Medicines annual pre-tax income for 2022 was $-0.552B, a 13.85% decline from 2021.
- Blueprint Medicines annual pre-tax income for 2021 was $-0.641B, a 303.56% decline from 2020.